Prognostic factors and validation of the histologic chronicity score for C3 glomerulopathy: a registry analysis

Safak Mirioglu1, Egemen Cebeci2, Halil Yazici3

  • 1Division of Nephrology, Bezmialem Vakif University Faculty of Medicine, Istanbul, Turkey.

Clinical Kidney Journal
|October 18, 2024
PubMed

Insights

Low hemoglobin levels predict poor outcomes in C3 glomerulopathy (C3G) patients. A high total chronicity score (TCS) indicates worse 3-year kidney survival, validating the C3G histologic index (C3G-HI) in this population.

Area of Science:

  • Nephrology
  • Pathology
  • Clinical Medicine

Background:

  • Limited data exists on prognostic factors for C3 glomerulopathy (C3G).
  • Validation of the C3G histologic index (C3G-HI) in diverse clinical settings is needed.
  • This study evaluates the chronicity score component of the C3G-HI and potential prognostic factors in a specific patient cohort.

Purpose of the Study:

  • To assess the prognostic value of the total chronicity score (TCS) from the C3G-HI.
  • To identify probable prognostic factors for C3G progression.
  • To validate the C3G-HI in a distinct patient population.

Main Methods:

  • A registry study included 74 patients from 20 centers with complete follow-up data.
  • Total chronicity score (TCS) was calculated based on glomerulosclerosis, interstitial fibrosis, tubular atrophy, and vascular sclerosis.
  • Primary composite outcome included doubling of serum creatinine, dialysis, kidney transplantation, stage 5 CKD, or death.

Main Results:

  • Hemoglobin levels were the only significant predictor of the primary composite outcome (aHR 0.67, P=.035).
  • TCS did not reach statistical significance in predicting the composite outcome (aHR 1.26, P=.08) but showed discriminative ability at 3 years (AUC 0.68, P=.028).
  • Patients with TCS ≥4 had significantly lower 3-year kidney survival (72.4%) compared to those with TCS <4 (91.1%, P=.036).

Conclusions:

  • Low hemoglobin levels are associated with adverse outcomes in C3G patients.
  • A TCS of 4 or higher predicts worse 3-year kidney survival.
  • The study validates the prognostic utility of the TCS component of the C3G-HI for 3-year kidney survival in this cohort.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
2
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
2
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
2